Decreased BIRC5-206 promotes epithelial-mesenchymal transition in nasopharyngeal carcinoma through sponging miR-145-5p

被引:0
作者
Xu, Weihua [1 ]
Hu, Junjie [1 ]
Ma, Zhichao [1 ]
Feng, Wanyi [2 ,3 ]
Gong, Wei [2 ,3 ]
Fu, Shengmiao [2 ,4 ]
Chen, Xinping [1 ]
机构
[1] Hainan Med Univ, Hainan Canc Hosp, Hainan Trop Canc Res Inst, Dept Med Lab,Affiliated Canc Hosp, 6 Changbin West,4th St, Haikou 570312, Hainan, Peoples R China
[2] Hainan Lvtou Med Lab Ctr, 6 Jinyu East Rd, Haikou 570206, Hainan, Peoples R China
[3] Hainan Univ, Sch Life Sci, Haikou 570228, Hainan, Peoples R China
[4] Hainan Gen Hosp, Hainan Med Coll, Hainan Hosp, Cent Lab, 19 Xiuhua Rd, Haikou 570311, Hainan, Peoples R China
关键词
nasopharyngeal carcinoma; BIRC5-206; epithelial-mesenchymal transition; miR-145-5p; CD40; SURVIVIN; CANCER; EXPRESSION; APOPTOSIS; GENE; PROLIFERATION; MIGRATION; CELLS; CD40; EMT;
D O I
10.1515/med-2024-1007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metastasis significantly contributes to the poor prognosis of advanced nasopharyngeal carcinoma (NPC). Our prior studies have demonstrated a decrease in BIRC5-206 expression in NPC, which promotes disease progression. However, the role of BIRC5-206 in the invasion and metastasis of NPC has not been fully elucidated. In this study, our objective was to explore the biological function and underlying mechanisms of BIRC5-206 in NPC. Additionally, we established an NPC mouse model of lung invasiveness using C666 cells to assess the impact of BIRC5-206 on NPC metastasis. Our results revealed that silencing BIRC5-206 inhibited apoptosis and enhanced the invasion of NPC cells, whereas its overexpression reversed these effects. Moreover, decreased BIRC5-206 expression significantly increased N-cadherin and Vimentin expression while reducing E-cadherin and occludin levels, both in vivo and in vitro. Additionally, silencing BIRC5-206 markedly augmented the formation of invasive foci in lung tissues. Rescue experiments further confirmed that decreased BIRC5-206 expression facilitates NPC metastasis via modulation of the miR-145-5p/CD40 signaling pathway. In summary, our study suggests that BIRC5-206 may serve as a potential prognostic biomarker and therapeutic target in the diagnosis and treatment of NPC.
引用
收藏
页数:18
相关论文
共 59 条
[1]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[2]   Survivin in Breast Cancer: A Review [J].
Antonio Martinez-Sifuentes, Manuel ;
Bassol-Mayagoitia, Susana ;
Nava-Hernandez, Martha P. ;
Ruiz-Flores, Pablo ;
Ramos-Trevino, Juan ;
Haro-Santa Cruz, Jorge ;
Anselmo Hernandez-Ibarra, Jose .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2022, 26 (09) :411-421
[3]   CD40 and CD40L expression in the chicken embryo aorta:: Possible role in the endothelial-mesenchymal transdifferentiation process [J].
Arciniegas, E ;
Becerra, A ;
De Sanctis, JB ;
Graterol, A ;
Ramírez, R .
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2003, 274A (02) :942-951
[4]   EMT, MET, Plasticity, and Tumor Metastasis [J].
Bakir, Basil ;
Chiarella, Anna M. ;
Pitarresi, Jason R. ;
Rustgi, Anil K. .
TRENDS IN CELL BIOLOGY, 2020, 30 (10) :764-776
[5]   Pan-cancer analysis identifies BIRC5 as a prognostic biomarker [J].
Beding, Anna Faldt ;
Larsson, Peter ;
Helou, Khalil ;
Einbeigi, Zakaria ;
Parris, Toshima Z. .
BMC CANCER, 2022, 22 (01)
[6]   Long Noncoding RNA and Cancer: A New Paradigm [J].
Bhan, Arunoday ;
Soleimani, Milad ;
Mandal, Subhrangsu S. .
CANCER RESEARCH, 2017, 77 (15) :3965-3981
[7]   Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Bossi, P. ;
Chan, A. T. ;
Licitra, L. ;
Trama, A. ;
Orlandi, E. ;
Hui, E. P. ;
Halamkova, J. ;
Mattheis, S. ;
Baujat, B. ;
Hardillo, J. ;
Smeele, L. ;
van Herpen, C. ;
Castro, A. ;
Machiels, J-P .
ANNALS OF ONCOLOGY, 2021, 32 (04) :452-465
[8]  
Chen XP, 2023, ANN CLIN LAB SCI, V53, P380
[9]   Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses [J].
Chen, Yu-Pei ;
Lv, Jia-Wei ;
Mao, Yan-Ping ;
Li, Xiao-Min ;
Li, Jun-Yan ;
Wang, Ya-Qin ;
Xu, Cheng ;
Li, Ying-Qin ;
He, Qing-Mei ;
Yang, Xiao-Jing ;
Lei, Yuan ;
Shen, Jia-Yi ;
Tang, Ling-Long ;
Chen, Lei ;
Zhou, Guan-Qun ;
Li, Wen-Fei ;
Du, Xiao-Jing ;
Guo, Rui ;
Liu, Xu ;
Zhang, Yuan ;
Zeng, Jing ;
Yun, Jing-Ping ;
Sun, Ying ;
Liu, Na ;
Ma, Jun .
MOLECULAR CANCER, 2021, 20 (01)
[10]   Nasopharyngeal carcinoma [J].
Chen, Yu-Pei ;
Chan, Anthony T. C. ;
Quynh-Thu Le ;
Blanchard, Pierre ;
Sun, Ying ;
Ma, Jun .
LANCET, 2019, 394 (10192) :64-80